HemaSphere Editorial Board


  • Jan Cools, Belgium

Deputy Editor-in-Chief

  • Claire Harrison, United Kingdom

Associate Editors

  • Stephen Ansell, USA
  • Martin Dreyling, Germany
  • Jeroen Eikenboom, The Netherlands
  • Adele Fielding, United Kingdom
  • Paolo Ghia, Italy
  • Simon Hallam, United Kingdom
  • Robert Hills, United Kingdom
  • Steffen Koschmieder, Germany
  • Martina Mückenthaler, Germany
  • Paula Rodríguez Otero, Spain
  • Juerg Schwaller, Switzerland
  • Francesca Vinchi, USA

Scientific Editors

  • Charles de Bock, Australia
  • Stephen Hibbs, United Kingdom
  • David Kent, United Kingdom
  • Edeghonghon Olayemi, Ghana


HemaSphere publishes results of highly relevant basic, translational, and clinical research in hematology. We are especially looking for strong studies reporting novel findings that are of high impact to the field of hematology. Review and Guideline articles provide clear overviews and discussions of new developments as well as recommendations for patient care.

HemaSphere is also the premier hematology information resource, which is covered by the HemaTopics section in the journal. This section provides insightful discussions on all aspects related to hematology, including summaries of important articles, reports of new therapies, discussions on EU policy, and other hematology news items.

HemaSphere is an open access journal, powered by the European Hematology Association, and dedicated to support hematology patient care, research and education worldwide.

HemaSphere is proud to have a 2022 Journal Impact Factor (JIF) of 9.1 (source: Journal Citation Reports, Clarivate). HemaSphere also has a Scopus 2022 CiteScore of 5.3. HemaSphere is fully indexed in PubMed Central (PMC), is a member of the Science Citation Expanded Index (SCIE) – Hematology, and is listed on the Directory of Open Access Journals (DOAJ).

Tasks and responsibilities

  • The Editorial Board is led by the Editor in Chief.
  • Under the leadership of the Editor in Chief, the Editorial Board is responsible for:
    • The timely review and selection of articles that serve the aims and scope of HemaSphere
    • The promotion of HemaSphere within the hematology community and beyond
    • Representing HemaSphere at various occasions
    • Guiding the quality and growth HemaSphere to become a reputable society journal for European hematology research and related scientific news
  • Actively participate in meetings and calls.


  1. Editor in Chief fixed advisors EHA Board
  2. Deputy Editor in Chief
  3. Up to 15 Associate Editors
  4. Up to 6 Scientific Editors


  • 3 years with the possibility of reappointment once


  • 2-3 physical meetings
  • Regular conference calls